Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04559945 · ClinicalTrials.gov registry record · NA

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

A NA study of Bradycardia and Cardiac Rhythm Disorder, sponsored by Abbott Medical Devices.

Active
Registry status
NA
Development phase
326
Enrollment target
20
Study locations

NCT04559945 is a NA study of Bradycardia and Cardiac Rhythm Disorder that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 326 participants, below the 4,401-participant average among 29 other Bradycardia trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04559945, a NA study of Bradycardia and Cardiac Rhythm Disorder, is active but no longer recruiting, sponsored by Abbott Medical Devices.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
326 participants
Enrollment target
20
Study locations

Study Summary

prospective, non-randomized, multi-center, international clinical study is designed to confirm the safety and effectiveness of the Aveir LP System in a subject population indicated for a VVI(R) pacemaker.

Conditions Studied

Bradycardia Cardiac Rhythm Disorder

Interventions

  • DEVICE Aveir VR Leadless Pacemaker System

Study Locations (20)

California

  • University of Southern California - Long Beach
  • Premier Cardiology Inc - Newport Beach
  • Huntington Memorial Hospital - Pasadena

Kentucky

  • St. Elizabeth Medical Center - South Unit - Edgewood
  • Baptist Health Lexington - Lexington
  • University of Kentucky - Lexington

Alabama

  • University Hospital - University of Alabama at Birmingham (UAB) - Birmingham
  • The Heart Center PC - Huntsville

Florida

  • Naples Heart Rhythm Specialists PA - Naples
  • Orlando Health - Orlando

Georgia

  • Piedmont Athens Regional Medical Center - Athens
  • Redmond Regional Medical Center - Rome

Kansas

  • Kansas University Medical Center - Kansas City
  • Kansas City Cardiac Arrhythmia Research Foundation - Overland Park

Michigan

  • Ascension St. John Hospital - Detroit
  • Sparrow Clinical Research Institute - Lansing

Arizona

  • Honor Health - Scottsdale

Trial Details

FieldValue
Enrollment Target 326 participants
Start Date 2020-11-13
Est. Completion 2023-08-31
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04559945

The ClinicalTrials.gov registry entry for NCT04559945 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,401-participant average among 29 other Bradycardia trials with a reported enrollment target (93% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bradycardia appearing as the primary indexed condition, and to 1 intervention - of which Aveir VR Leadless Pacemaker System is the first listed.

NCT04559945 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Kentucky, Alabama.

Frequently Asked Questions

What is clinical trial NCT04559945 about?

NCT04559945 is a clinical study titled "The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System". prospective, non-randomized, multi-center, international clinical study is designed to confirm the safety and effectiveness of the Aveir LP System in a subject population indicated for a VVI(R) pacemaker.

What is the current status of trial NCT04559945?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 326 participants. The study started on 2020-11-13. Estimated completion is 2023-08-31.

What conditions does trial NCT04559945 study?

This clinical trial studies the following conditions: Bradycardia, Cardiac Rhythm Disorder.

What interventions are being tested in trial NCT04559945?

The interventions under investigation include: Aveir VR Leadless Pacemaker System (DEVICE).

Who is sponsoring clinical trial NCT04559945?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04559945 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bradycardia

All registered trials for this condition

Cardiac Rhythm Disorder

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.